Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03975114
Title A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) (MILES-5)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute, Naples
Indications

lung non-squamous non-small cell carcinoma

lung squamous cell carcinoma

Therapies

Durvalumab + Tremelimumab

Durvalumab

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST